Misonix Inc (MSON):企業の財務・戦略的SWOT分析

◆英語タイトル:Misonix Inc (MSON) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12039
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Misonix Inc (MSON) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Misonix Inc (Misonix) is a medical technology company that provides ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery procedures. The company’s major products include BoneScalpel and BoneScalpel MIS cutting system; SonaStar surgical aspirator; SonicOne wound cleansing and debridement system. Its products are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, general surgery, spine surgery and other surgical and medical applications. It has production facility in Farmingdale, New York, and sells its products through direct sales persons and sales agents in the US and through an extensive network of distributors across the world. Misonix is headquartered in New York, the US.

Misonix Inc Key Recent Developments

Nov 08,2018: Misonix fiscal 2019 first quarter revenue rises 29% to record $9.4 million
Nov 08,2018: Misonix fiscal 2019 first quarter revenue rises 29% to record $9.4 million
Sep 05,2018: Misonix reports record fourth quarter and fiscal year 2018 revenue
Jul 19,2018: Misonix appoints Gwen Watanabe as board director
May 07,2018: Misonix Reports Record Third Quarter Revenue

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Misonix Inc – Key Facts 6
Misonix Inc – Key Employees 7
Misonix Inc – Key Employee Biographies 8
Misonix Inc – Major Products and Services 9
Misonix Inc – History 10
Misonix Inc – Company Statement 15
Misonix Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Company Overview 17
Misonix Inc – Business Description 18
Business Segment: Consumables 18
Overview 18
Performance 18
Business Segment: Equipment 18
Overview 18
Performance 18
Business Segment: License 18
Overview 18
Performance 19
Geographical Segment: Domestic 19
Performance 19
Geographical Segment: International 19
Performance 19
R&D Overview 19
Misonix Inc – SWOT Analysis 20
SWOT Analysis – Overview 20
Misonix Inc – Strengths 20
Misonix Inc – Weaknesses 21
Misonix Inc – Opportunities 22
Misonix Inc – Threats 23
Misonix Inc – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Misonix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31
Misonix Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32
Misonix Inc, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Nov 08, 2018: Misonix fiscal 2019 first quarter revenue rises 29% to record $9.4 million 34
Sep 05, 2018: Misonix reports record fourth quarter and fiscal year 2018 revenue 35
Jul 19, 2018: Misonix appoints Gwen Watanabe as board director 36
May 07, 2018: Misonix Reports Record Third Quarter Revenue 37
Feb 06, 2018: Misonix Reports Record Second Quarter Revenue 38
Nov 07, 2017: Misonix Reports First Quarter Fiscal Year 2018 Financial Results 39
Aug 23, 2017: Misonix Appoints Joseph Dwyer as Chief Financial Officer 40
Aug 22, 2017: Misonix Reports Fiscal Year 2017 Financial Results 41
May 02, 2017: Misonix Reports Third Quarter Fiscal Year 2017 Financial Results 42
Mar 13, 2017: Misonix Announces Second Quarters of Fiscal 2017 43
Section 6 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Misonix Inc, Key Facts 6
Misonix Inc, Key Employees 7
Misonix Inc, Key Employee Biographies 8
Misonix Inc, Major Products and Services 9
Misonix Inc, History 10
Misonix Inc, Subsidiaries 16
Misonix Inc, Key Competitors 24
Misonix Inc, Ratios based on current share price 25
Misonix Inc, Annual Ratios 26
Misonix Inc, Annual Ratios (Cont...1) 27
Misonix Inc, Interim Ratios 29
Misonix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31
Misonix Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32
Misonix Inc, Recent Deals Summary 33
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List of Figures
Misonix Inc, Performance Chart (2014 - 2018) 28
Misonix Inc, Ratio Charts 30
Misonix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31
Misonix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 32

★海外企業調査レポート[Misonix Inc (MSON):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National HealthCare Corp (NHC):製薬・医療:M&Aディール及び事業提携情報
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • MedImmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune Ltd (MedImmune), formerly Cambridge Antibody Technology Ltd, is a subsidiary of AstraZeneca Plc, is a research and development company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respi …
  • Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析
    Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • InterGen Services, Inc.:電力:M&Aディール及び事業提携情報
    Summary InterGen Services, Inc. (InterGen) is an energy utility that develops, owns, and operates power generation assets which produce energy from coal, gas and renewable sources. It is jointly owned by Ontario Teachers’ Pension Plan and China Huaneng Group/Yudean Guandong Group. The company also o …
  • Agios Pharmaceuticals Inc (AGIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Career Education Corporation (CECO):企業の財務・戦略的SWOT分析
    Career Education Corporation (CECO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Territorial Generation Company No. 11:企業の戦略的SWOT分析
    Territorial Generation Company No. 11 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Hsh Nordbank Private Banking:企業の戦略・SWOT・財務分析
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Batory Foods, Inc.:企業の戦略・SWOT・財務情報
    Batory Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Batory Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mellors Catering Services:企業の戦略・SWOT・財務情報
    Mellors Catering Services - Strategy, SWOT and Corporate Finance Report Summary Mellors Catering Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • NSK Ltd (6471):企業の財務・戦略的SWOT分析
    NSK Ltd (6471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Tokyo Broadcasting System Holdings Inc (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings Inc (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Heptares Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Heptares Therapeutics Ltd (Heptares), a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise …
  • Stockmann plc (STCBV):企業の財務・戦略的SWOT分析
    Stockmann plc (STCBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • GROUPE ADEO SA:戦略・SWOT・企業財務分析
    GROUPE ADEO SA - Strategy, SWOT and Corporate Finance Report Summary GROUPE ADEO SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Jelf Group PLC:企業のM&A・事業提携・投資動向
    Jelf Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jelf Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • OWC Pharmaceutical Research Corp (OWCP):製薬・医療:M&Aディール及び事業提携情報
    Summary OWC Pharmaceutical Research Corp (OWC Pharmaceutical), formerly Dynamic Applications Corp, is a drug development company that discovers, develops, and commercializes cannabis-based novel therapeutics products and treatments for several medical conditions. The company offers sublingual solubl …
  • Dr. Reddy’s Laboratories Limited:企業の戦略・SWOT・財務情報
    Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report Summary Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Inform Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆